Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4803136

Cc1cc(C(=O)OCc2ccccc2)cc(C)c1OC(=O)c1c2ccccc2[n+](C)c2ccc(O)cc12.O=C([O-])C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.37
ACHE P22303 1/20 0.37
MAPT P10636 6/20 0.35
GAA P10253 4/20 0.35
KDM4E B2RXH2 3/20 0.35
PKM P14618 2/20 0.35
KMT2A Q03164 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
F10 P00742 1/20 0.34
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
AKR1B1 P15121 1/20 0.33
ALOX5 P09917 1/20 0.33
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13979971 0.93 LMNA (0.43) LMNAMAPTGAAKDM4EPKM
Trifluoromethanesulfonic Acid SCHEMBL4197431 0.92 LMNA (0.36) LMNAMAPTGAAKDM4EPKM
Trifluoroacetic Acid SCHEMBL7099563 0.91 ACHE (0.36) LMNAACHEMAPTKMT2ATDP1
Trifluoroacetic Acid SCHEMBL4796975 0.88 ACHE (0.34) ACHEKMT2ATDP1SLC6A2SLC6A3
SCHEMBL8909050 0.82 MAPT (0.39) LMNAMAPTKMT2ATDP1SLC6A2
SCHEMBL7531533 0.82 MAPT (0.37) LMNAMAPTKMT2ATDP1SLC6A2
SCHEMBL4192297 0.81 GAA (0.37) LMNAACHEMAPTGAAKDM4E
SCHEMBL13638337 0.81 MAPT (0.39) LMNAACHEMAPTGAAKDM4E
Bromide SCHEMBL4190244 0.81 GAA (0.36) LMNAACHEMAPTGAAKDM4E
Trifluoroacetic Acid SCHEMBL8438517 0.81 ACHE (0.35) ACHEMAPTKDM4EKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459284-B2 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2008-12-02 US disclosed
US-20060202179-A1 Chemiluminescent Acridinium Compounds and Analogues thereof as Substrates of Hydrolytic Enzymes BAYER CORPORATION (US) 2006-09-14 US disclosed
US-7097995-B2 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes BAYER CORP. (US) 2006-08-29 US disclosed
EP-1203091-B1 CHEMILUMINESCENT SUBSTRATES OF HYDROLYTIC ENZYMES SUCH AS PHOSPHATASES BAYER AG (US) 2005-03-16 EP disclosed
US-20050032147-A1 Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes BAYER CORPORATION 2005-02-10 US disclosed
US-6783948-B1 USED IN DIAGNOSTIC IMMUNOASSAYS; HAS DISTINCTLY DIFFERENT LIGHT EMISSION CHARACTERISTICS (EMISSION WAVELENGTH, KINETICS, OR QUANTUM YIELD) BAYER CORPORATION 2004-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032147-A1 Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes MPO, LPO, PGLS LMNA 119/4885ACHE 9/4885MAPT 4393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.